No Detail Found!

Pharmacological implications of psoriasis and superficial fungal infections: Analysis of risk factors and underlying mechanisms

Author(s)
Tayier Tuerhong The First People`s Hospital of Kashi, Dermatology , China.
Muyesaier Nasier The First People`s Hospital of Kashi, Dermatology , China.
Renaguli Maimaiti The First People`s Hospital of Kashi, Dermatology , China.
Zhang Yan The First People`s Hospital of Kashi, Dermatology , China.
Zheng Gang The First People`s Hospital of Kashi, Dermatology , China.
He Jinxia The First People`s Hospital of Kashi, Dermatology , China.
Abudoushalamu Abudouwake The First People`s Hospital of Kashi, Dermatology , China.
Maimaitisiyiti Maimaitiyiming The First People`s Hospital of Kashi, Dermatology , China.
Abstract
Psoriasis (Ps) is a chronic inflammatory skin condition that is often accompanied by superficial fungal infections, which may exacerbate disease severity and impact treatment effectiveness. This study investigates the association between fungal infections and psoriasis severity in the Kashgar region and identifies risk factors relevant to pharmacological interventions. A cross-sectional analysis was conducted among 196 psoriasis patients, evaluating clinical characteristics, psoriasis area severity index (PASI) scores, and the presence of fungal infections through microscopy and culture. Logistic regression analysis was used to identify independent risk factors, providing insights for targeted pharmacological approaches. Patients with fungal infections exhibited significantly higher PASI scores and longer disease duration (P < 0.05). Key risk factors included head and nail involvement. These findings suggest that managing fungal infections may optimize psoriasis treatment outcomes. This study highlights the link between fungal infections and psoriasis severity, advocating for integrated therapeutic strategies. The findings provide a foundation for future pharmacological research aimed at improving patient outcomes.
Publication Details
Page(s) 737-743
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Risk factors, Psoriasis, fungal infections, Psoriasis, PASI score, pharmacological interventions, treatment optimization
References
Sweet WL,Smoller BR .1997 .Differential proliferation of endothelial cells and keratinocytes in psoriasis and spongiotic dermatitis. J Cutan Pathol., 24(6) : 356-363.
Dascalu RC,Barbulescu AL,Stoica LE,Ciurea RN,Vreju AF,Crivei C,Buga AM,Sandu RE,Ciurea ME .2024 .A contemporary, multifaced insight into psoriasis pathogenesis. J. Pers. Med, 14(5) : 535.
Langan EA,Griffiths CEM,Solbach W,Knobloch K,Zillikens D,Thaçi D D .2018 .The role of the microbiome in psoriasis: Moving from disease description to treatment selection? Br J Dermatol. , 178(5) : 1020-1027.
Christophers E .2001 .Psoriasis-epidemiology and clinical spectrum. Clin. Exp, 26(4) : 314-320.
Zhou S and Yao Z .2022 .Roles of infection in psoriasis. Int J Mol Sci., 23(13) : 6955.
Campione E,Cosio T,Pistoia ES,Lanna C,Diluvio L,Orlandi A,Bianchi L A .2024 .Prevalence of fungal colonization among patients with psoriasis in difficultto-treat areas: impact of apremilast on mycotic burden and clinical outcomes. Front Immunol, 15 : 1508489.
Baroni A,Paoletti I,Ruocco E,Agozzino M,Tufano MA,Donnarumma G .2004 .Possible role of Malassezia furfur in psoriasis: Modulation of TGF-β1, integrin and HSP70 expression in human keratinocytes and in the skin of psoriasis-affected patients. J. Cutan. Pathol., 31(1) : 35-42.
Méndez-Tovar LJ,Arévalo-Lopez A,Domínguez-Aguilar S,Lopez-Martínez R .2015 .Onychomycosis frequency in psoriatic patients in a tertiary care hospital. Rev. Med. Inst. Mex Seguro Soc., 53(3) : 374-379.
Theelen B,Cafarchia C,Gaitanis G,Bassukas ID,Boekhout T,Dawson TL .2018 .Malassezia ecology, pathophysiology and treatment. Med Mycol, 56(suppl 1) : S10-S25.
Stehlikova Z,Kostovcik M,Kostovcikova K,Hudcovic T,Tlaskalova-Hogenova H,Kverka M H .2019 .Dysbiosis of skin microbiota in psoriatic patients: Cooccurrence of fungal and bacterial communities. Front Microbiol, 10 : 438.
Fang H,Hou Y,Zhuang H,Liu Y,Li J .2022 .The effects of Malassezia in the activation of Interleukin (IL)-23/IL-17 axis in psoriasis. , 45(2) : 130-137.
Gao Z,Perez-Perez GI,Chen Y,Blaser MJ Y .2010 .Quantitation of major human cutaneous bacterial and fungal populations. J. Clin. Microbiol, 48(10) : 3575-3581.
Rudramurthy S M P,Chakrabarti A,Dogra S,Handa S,Kaur R .2014 .Association of Malassezia species with psoriatic lesions. Mycoses, 57(8) : 483-488.
Wal P,Saraswat N,Vig H N .2022 .A detailed insight onto the molecular and cellular mechanism of action of the antifungal drugs used in the treatment of superficial fungal infections. Curr Drug Ther., 17(3) : 148-159.
Mba IE,Nweze EI .2020 .Mechanism of Candida pathogenesis: Revisiting the vital drivers. Eur J Clin Microbiol Infect Dis, 39(10) : 1797-1819.
De Aguiar Cordeiro R,Reis AT,Lima XTV,Pontes L D S XTV,Rocha MFG,Sidrim JJC,Brilhante RSN .2023 .Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals. , 54(1) : 169-177.
Waldman A,Gilhar A,Duek L,Berdicevsky I .2001 .Incidence of Candida in psoriasis-a study on the fungal flora of psoriatic patients. , 44(3-4) : 77-81.
Picciani B L S ,Michalski-Santos B,Carneiro S,Avelleira JCR,Azulay DR,Pinto JM,Dias EP JM .2013 .Oral candidiasis in patients with psoriasis: Correlation of oral examination and cytopathological evaluation with psoriasis disease severity and treatment. J Am Acad Dermatol., 68(6) : 986-991.
Sarvtin MT,Shokohi T,Hajheydari Z,Jamshidi M,Rezaei-Matehkolaei A .2014 .Evaluation of candidal colonization and specific humoral responses against Candida albicans in patients with psoriasis. Int J Dermatol., 53(12) : e555-e560.
Aldona P,Ewelina G,Mateusz S,Magdalena C,Roman JN C .2018 .Prevalence and possible role of Candida species in patients with psoriasis: A systematic review and meta-analysis. Mediators Inflamm, : 1-7.
Lesan S,Toosi R,Aliakbarzadeh R,Ahrari F,Yazdanpanah MJ F .2018 .Oral Candida colonization and plaque type psoriasis: Is there any relationship? J Investig Clin Dent. , 9(3) : e12335.
Zander N,Schafer I,Radtke M,Augustin M M .2017 .Dermatological comorbidity in psoriasis: Results from a large-scale cohort of employees. Arch Dermatol Res., 309(5) : 349-356.
0

Citations

0

Downloads

68

Views